- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05098652
Coaching Dementia Caregivers to Master Care-Resistant Behavior (CuRB-IT)
May 4, 2026 updated by: Rita A. Jablonski, University of Alabama at Birmingham
Coaching Dementia Caregivers to Master Care-Resistant Behavior and Improve Coping Strategies
266 family caregivers will be randomly assigned to either immediate intervention or delayed intervention groups.
All caregivers will complete baseline surveys and 3 weeks of daily diaries.
The immediate intervention group will receive 12 weeks of CuRB-IT.
They will complete 3 rounds of 3-week daily diaries followed by an intermittent survey at 12 week intervals for the next 33 weeks.
The delayed intervention group will receive 12 weeks of attention, complete 1 round of 3-week daily diaries followed by an intermittent survey, then complete 12 weeks of CuRB-IT, and complete 2 rounds of 3--week daily diaries followed by an intermittent survey at 12-week intervals for the next 18 weeks.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
The purposes of the delayed-intervention randomized clinical trial (N=266) are to:
Care-Resistant Behavior Internet Training (CuRB-IT).
- examine the efficacy of CuRB-IT in increasing the self-efficacy of family caregivers of persons living with dementia to handle care-resistant behaviors (CRB);
- further test the efficacy of CuRB-IT in improving caregivers coping strategies (a) among the experimental (immediate-intervention group) as compared to the control (delayed-intervention group) (between groups) and (b) within-person from pre- to post- intervention;
- examine intervention decay at 3- and 6-months post intervention to determine performance of intervention and inform scheduling of booster sessions;
- assess the efficacy of the CuRB-IT intervention in preventing onset of poor coping strategies by family caregivers;
- test the hypothesized mechanism of action that increased CRB self-efficacy and use of CuRB-IT problem-focused coping strategies mediate the relationship between CRB stress appraisal and caregiving activities.
Study Type
Interventional
Enrollment (Estimated)
266
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35244
- University of Alabama at Birmingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 95 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 1)Caregiver of any race or gender who is aged >18 years
- 2) provides unpaid care,
- 3) cares for a spouse/common-law, sibling, parent or grandparent (or in-law, aged 60+ years),
- 4) lives with or shares cooking facilities with the care recipient,
- 5) Care recipient has mild cognitive impairment or dementia as identified using the Quick Dementia Rating System instrument,
- 6) the care provided consists of help with at least 2 Instrumental Activities of Daily Living or one Activity of Daily Living,
- 7) the care recipient is resistant to receiving assistance with, or refuses to do, at least one instrumental or activity of daily living
Exclusion Criteria:
- 1) persons who cannot speak/read English
- 2) who do not have reliable access to a smart phone or internet
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Immediate Intervention
Complete baseline survey, complete 3 weeks of daily diaries and intermittent survey, receive 12 weeks of CurB-IT, then complete 3 rounds of 21-day daily diaries and intermittent surveys while receiving attention during the 12-week intervals between daily diaries.
|
9 1-hour coaching sessions delivered over a videoconferencing platform (Zoom); 6 delivered weekly, 3 delivered biweekly
|
|
Active Comparator: Delayed intervention
Complete baseline survey, complete 3 weeks of daily diaries, receive 12 weeks of attention, complete 3 weeks of daily diaries and 1 intermittent survey, receive 12 weeks of CurB-IT, then complete 2 rounds of 21-day daily diaries and intermittent surveys while receiving attention during the 12-week intervals between daily diaries.
|
9 1-hour coaching sessions delivered over a videoconferencing platform (Zoom); 6 delivered weekly, 3 delivered biweekly
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in frequency of care-resistant behaviors and other dementia-related behaviors measured by a 19-item self-report scale (yes/no) for dementia family caregivers
Time Frame: Daily during weeks 1, 2, and 3
|
Experimental and control
|
Daily during weeks 1, 2, and 3
|
|
Change in frequency of care-resistant behaviors and other dementia-related behaviors measured by a 19-item self-report scale (yes/no) for dementia family caregivers
Time Frame: Daily during weeks 15, 16, and 17
|
Experimental and control
|
Daily during weeks 15, 16, and 17
|
|
Change in frequency of care-resistant behaviors and other dementia-related behaviors measured by a 19-item self-report scale (yes/no) for dementia family caregivers
Time Frame: Daily during weeks 37, 38, and 39
|
Experimental and control
|
Daily during weeks 37, 38, and 39
|
|
Change in frequency of care-resistant behaviors and other dementia-related behaviors measured by a 19-item self-report scale (yes/no) for dementia family caregivers
Time Frame: Daily during weeks 49, 50, and 51
|
Experimental and control
|
Daily during weeks 49, 50, and 51
|
|
Change in caregiver responses to dementia-related behaviors
Time Frame: Immediately after enrollment
|
Experimental (immediate) and control (delayed intervention).
Measured using yes/no responses to 8 items (2 from the Conflicts Tactics Scale Revised, 2 from the Conflicts Tactics Scale modified for Older Adults, and 4 from the Conflict Tactics Scale for Child Mistreatment).
|
Immediately after enrollment
|
|
Change in caregiver responses to dementia-related behaviors
Time Frame: Once at week 15
|
Experimental (immediate) and control (delayed intervention).
Measured using yes/no responses to 8 items (2 from the Conflicts Tactics Scale Revised, 2 from the Conflicts Tactics Scale modified for Older Adults, and 4 from the Conflict Tactics Scale for Child Mistreatment).
|
Once at week 15
|
|
Change in caregiver responses to dementia-related behaviors
Time Frame: Once at week 37
|
Experimental (immediate) and control (delayed intervention).
Measured using yes/no responses to 8 items (2 from the Conflicts Tactics Scale Revised, 2 from the Conflicts Tactics Scale modified for Older Adults, and 4 from the Conflict Tactics Scale for Child Mistreatment).
|
Once at week 37
|
|
Change in caregiver responses to dementia-related behaviors
Time Frame: Once at week 49
|
Experimental (immediate) and control (delayed intervention).
Measured using yes/no responses to 8 items (2 from the Conflicts Tactics Scale Revised, 2 from the Conflicts Tactics Scale modified for Older Adults, and 4 from the Conflict Tactics Scale for Child Mistreatment).
|
Once at week 49
|
|
Change in caregiver self-efficacy coping skills
Time Frame: Immediately after enrollment
|
Experimental (immediate) and control (delayed intervention).
Measured using 14 items from the Brief Coping Scale.
|
Immediately after enrollment
|
|
Change in caregiver self-efficacy coping skills
Time Frame: Once at week 15
|
Experimental (immediate) and control (delayed intervention).
Measured using 14 items from the Brief Coping Scale.
|
Once at week 15
|
|
Change in caregiver self-efficacy coping skills
Time Frame: Once at week 37
|
Experimental (immediate) and control (delayed intervention).
Measured using 14 items from the Brief Coping Scale.
|
Once at week 37
|
|
Change in caregiver self-efficacy coping skills
Time Frame: Once at week 49
|
Experimental (immediate) and control (delayed intervention).
Measured using 14 items from the Brief Coping Scale.
|
Once at week 49
|
|
Change in caregiver self-efficacy measured by selection of items from 10-item CurB-CuRB-IT Strategy checklist
Time Frame: Once at week 15
|
Experimental (immediate)
|
Once at week 15
|
|
Change in caregiver self-efficacy measured by selection of items from 10-item CurB-CuRB-IT Strategy checklist
Time Frame: Once at week 37
|
Experimental (immediate)
|
Once at week 37
|
|
Change in caregiver self-efficacy measured by selection of items from 10-item CurB-CuRB-IT Strategy checklist
Time Frame: Once at week 49
|
Experimental (immediate)
|
Once at week 49
|
|
Change in caregiver self-efficacy measured by selection of items from 10-item CurB-CuRB-IT Strategy checklist
Time Frame: Once at week 37
|
Control (delayed)
|
Once at week 37
|
|
Change in caregiver self-efficacy measured by selection of items from 10-item CurB-CuRB-IT Strategy checklist
Time Frame: Once at week 49
|
Control (delayed)
|
Once at week 49
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Rita A Jablonski, PhD, University of Alabama at Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2023
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
May 31, 2027
Study Registration Dates
First Submitted
August 17, 2021
First Submitted That Met QC Criteria
October 18, 2021
First Posted (Actual)
October 28, 2021
Study Record Updates
Last Update Posted (Actual)
May 6, 2026
Last Update Submitted That Met QC Criteria
May 4, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300007452
- R01AG074255 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All research data produced by this project will be self-archived at the University of Michigan's NIA-funded National Archive of Computerized Data on Aging.
The storage of our research product here will permit many researchers free access to our data in perpetuity.
Our archived study will principally include our original (but anonymized) databases as well as any "cleaned," computed, and recoded measures that we produce for or is produced by our analysis.
Our project deliverables will include the quantitative databases, a well-documented statistical packaging (SPSS) system file with variable and values labels, a data user guide that includes all SPSS and related computational and analysis syntax code, summary statistics (frequency distributions, means, etc.) for all quantitative variables, a copy of applicable subject consent form, human subject application and the institutional review board (IRB) approval letter, and a blank copy of the survey instrument and interviewer guide.
IPD Sharing Time Frame
6 months after conclusion of study; in perpetuity
IPD Sharing Access Criteria
1) a commitment only to use the data for research purposes and not to identify any individual participant; 2) a commitment to securing the data using appropriate computer technology; and 3) a commitment to destroy or return the data after analyses are completed.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
The University of Hong KongNot yet recruiting
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
Clinical Trials on CuRB-IT
-
Benjamin Van Voorhees, MD, MPHCompleted
-
Onward Health, IncNational Institute on Aging (NIA)RecruitingDementia | Cognitive Decline | Alzheimer Disease or Associated DisorderUnited States
-
Benjamin Van Voorhees, MD, MPHNorthwestern University; NorthShore University HealthSystem; Advocate Health... and other collaboratorsCompletedMajor Depression | Depressive EpisodesUnited States
-
University of Texas at AustinBaylor College of Medicine; University of Kansas Medical CenterCompleted
-
Philips Clinical & Medical Affairs GlobalCompletedPeripheral Artery Disease | Critical Limb IschemiaAustria
-
Oslo University HospitalCentre for Appearance Research, University of the West of England, UKEnrolling by invitationBurns | Cleft Lip and Palate | Craniofacial Abnormalities | Skin Condition | Other Conditions Leading to a Visible DifferenceNorway
-
University of AarhusUnknownDysfunction of Vestibular SystemDenmark
-
ShireCompleted
-
Integro TheranosticsCompletedBreast Cancer | DCIS | Invasive Duct Carcinoma of BreastUnited States
-
University of AlbertaCanadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions and other collaboratorsCompletedPediatric ObesityCanada